- E-mail : info@wellonapharma.com
- Call : +91-261-2571244
- Mob: +91-7490041245
Malaria remains one of the world’s most persistent public health challenges, affecting millions of people each year—particularly in tropical and subtropical regions. To combat this life-threatening disease effectively, Artemether 80mg Lumefantrine 480mg Tablets have emerged as one of the most reliable and WHO-approved treatment options.
As a leading Artemether 80mg Lumefantrine 480mg Tablets wholesaler and supplier, Wellona Pharma plays a vital role in ensuring global access to quality-assured anti-malarial formulations. With a strong presence across international markets, Wellona Pharma supports hospitals, distributors, and health ministries with consistent pharmaceutical supply backed by world-class manufacturing practices.
Artemether and Lumefantrine are powerful antimalarial active pharmaceutical ingredients (APIs) used in artemisinin-based combination therapy (ACT)—the gold standard for malaria treatment as recommended by the World Health Organization (WHO).
Artemether acts rapidly to eliminate Plasmodium parasites in the bloodstream, providing quick symptomatic relief.
Lumefantrine complements Artemether by preventing recurrence through prolonged therapeutic activity.
This combination effectively treats uncomplicated malaria, primarily caused by Plasmodium falciparum, one of the most dangerous malaria parasites.
As a reputed Artemether 80mg Lumefantrine 480mg Tablets supplier, Wellona Pharma has built a strong international reputation for quality, reliability, and service excellence. The company’s unwavering commitment to global health drives its leadership in antimalarial product manufacturing and export.
Wellona Pharma’s production facilities are WHO-GMP and ISO-certified, ensuring that every batch meets international standards of safety, efficacy, and consistency. These state-of-the-art plants use advanced technology for tablet formulation, coating, and blister packaging.
The company follows rigorous Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP). Each batch undergoes multiple levels of analytical testing, including potency, purity, and dissolution, ensuring that all Artemether Lumefantrine Tablets perform effectively under real-world conditions.
With exports spanning more than 85 countries, Wellona Pharma stands among the world’s preferred pharmaceutical exporters. Its efficient logistics and regulatory support help wholesalers and distributors receive timely supplies, even in remote malaria-endemic regions.
Wellona’s regulatory department ensures full compliance with international authorities, maintaining dossiers and certifications that simplify product registration for importers and government tenders.
Integrity and transparency are at the heart of Wellona Pharma’s global operations. The company adheres to international trade ethics, providing accurate documentation, product traceability, and fair pricing for all business partners.
These tablets are indicated for the treatment of uncomplicated malaria caused by Plasmodium falciparum or mixed infections involving this parasite. They are effective in both adults and pediatric patients when administered under medical supervision.
Rapid action: Quickly eliminates malaria parasites and relieves symptoms like fever and chills.
Dual mechanism: Artemether targets fast parasite clearance, while Lumefantrine ensures sustained suppression.
WHO-approved therapy: Recommended globally as part of ACT for uncomplicated malaria.
Reduced relapse: Provides longer protection against reinfection.
Safe and well-tolerated: Proven safety profile across multiple demographics.
Malaria continues to threaten lives in Africa, Asia, and Latin America. The pharmaceutical industry plays a crucial role in ensuring equitable access to anti-malarial treatments.
According to global health reports, the need for Artemether Lumefantrine combination therapy is increasing due to drug resistance in older antimalarial drugs like chloroquine. As a result, reliable wholesalers and suppliers such as Wellona Pharma have become essential partners in maintaining steady global medicine supply chains.
Partnering with Wellona Pharma offers numerous advantages for importers, distributors, and healthcare organizations worldwide:
WHO-GMP & ISO-certified manufacturing facilities.
Consistent supply with flexible bulk and private-label options.
Experienced export team with complete regulatory documentation support.
Commitment to global health and ethical business practices.
Proven track record in antimalarial and critical care formulations.
Whether you’re a pharmaceutical wholesaler, government tender participant, or medical distributor, Wellona Pharma ensures top-quality, competitively priced Artemether 80mg Lumefantrine 480mg Tablets with reliable global logistics support.
To explore partnerships or place a bulk order, visit the official Wellona Pharma Contact Page.
As malaria continues to challenge public health systems, the demand for effective, reliable, and affordable anti-malarial solutions grows stronger. Wellona Pharma, a trusted Artemether 80mg Lumefantrine 480mg Tablets wholesaler and supplier, is committed to improving global access to high-quality pharmaceutical products that save lives.
With its world-class facilities, professional integrity, and global distribution network, Wellona Pharma continues to strengthen its role as a dependable partner in the worldwide fight against malaria.
For more information or partnership opportunities, visit https://wellonapharma.com/contact-us today.
